Bromide

Bromide

SCHEMBL4353452

Br.CC(C)(C)c1cc(C(=O)Cn2c(C#N)cn(Cc3ccccc3)c2=N)cc(C(C)(C)C)c1O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.43
F2R P25116 10/20 0.63
MAOB P27338 4/20 0.43
BCHE P06276 2/20 0.43
MAOA P21397 2/20 0.43
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14346327 0.99 F2R (0.64) F2RMAOBBCHEMAOAACHE
Bromide SCHEMBL4340422 0.92 F2R (0.63) F2RMAOBBCHEMAOAACHE
SCHEMBL14346325 0.91 F2R (0.64) F2RMAOBBCHEMAOAACHE
Bromide SCHEMBL4351865 0.86 F2R (0.67) F2RMAOBBCHEMAOAACHE
Bromide SCHEMBL4340591 0.85 F2R (0.66) F2RMAOBBCHEMAOAACHE
SCHEMBL14346249 0.85 F2R (0.69) F2RMAOBBCHEMAOAACHE
SCHEMBL14369137 0.85 F2R (0.53) F2RMAOBBCHEMAOAACHE
Bromide SCHEMBL5585203 0.84 F2R (0.65) F2RMAOBBCHEMAOAACHE
SCHEMBL14346256 0.84 F2R (0.67) F2RMAOBBCHEMAOAACHE
SCHEMBL6849519 0.83 F2R (0.66) F2RMAOBBCHEMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391456-B1 2-IMINOIMIDAZOLE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2009-07-22 EP disclosed
US-7304083-B2 2-iminoimidazole derivatives (2) EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-12-04 US disclosed
US-20050004197-A1 2-iminoimidazole derivatives (2) EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004197-A1 2-iminoimidazole derivatives (2) H1-2, H1-3, H1-4 ACHE 4210/4885F2R 2393/4885MAOB 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.